Welcome to MyStrategist

Quickly uncover the breadth and depth of the editorial offerings found only in MedTech Strategist and Market Pathways – the medtech industry’s leading sources of global business, regulatory, and reimbursement analysis and intelligence on an all-in-one, digital platform. Think Strategically. Subscribe Today

Subscribe Browse

Latest from Market Pathways

Global Medical Device Regulatory, Reimbursement, and Policy Review

Pathways' Picks

TEMPO Selection, TAVR Coverage, AI Picks, and India’s Software Guidance

In this week’s Pathways Picks: FDA selects Dexcom as the first participant in the digital health TEMPO pilot; Industry and hospital groups call out CMS for tightening its proposed coverage policy language for transcatheter aortic valve replacements; UK issues AI regulation case studies; Health Canada complains of too much information; India finalizes its guidance on medical device software; and more global medtech policy updates.

Start a free trial and unlock 5-days of exclusive subscriber-only access to MedTech Strategist & Market Pathways

Start Trial

Latest from MedTech Strategist

Actionable intelligence exploring the people, challenges, and opportunities impacting the global medtech community.

Start-Ups

SquareMind: In Dermatology, Robotics Solve for Access and Consistency

Skin cancer is the most commonly diagnosed cancer in the US, but the dermatology specialty’s capacity for skin-checks can’t meet demand. SquareMind has developed a robot for whole-body dermoscopic skin imaging, to increase clinical efficiency and consistency, and to enable longitudinal tracking.

Don't Just Advertise... Strategize!

Advertise with MedTech Strategist and be seen by medtech's most influential executives.

Learn More

Latest from Community Blog

MedTech Strategist's free Community Blog explores the passion behind the people, technologies, and companies impacting the global device space.

Our strategic publications provide actionable intelligence to support each member of your organization. Check to see if your company has access.

Learn More